Although BTK inhibitors have revolutionized the treatment strategy for B-cell malignancies, induction of AF, hypertension, and ventricular arrhythmias has been demonstrated by BTK inhibitors in clinical use [158, 159] (Table 5). Here, BTK is linked to atrial fibrillation.